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Objective: Fibrosis is a major contributor to joint stiffness in osteoarthritis (OA). We investigated several
factors associated with the persistence of transforming growth factor beta (TGF-b)-induced ﬁbrosis and
whether these factors also play a role in OA-related ﬁbrosis.
Design:Mice were injected intra-articularly (i.a.) with an adenovirus encoding either TGF-b or connective
tissue growth factor (CTGF). In addition, we induced OA by i.a. injection of bacterial collagenase into the
right knee joint of C57BL/6 mice. mRNA was isolated from the synovium for Q-PCR analysis of the gene
expression of various extracellular matrix (ECM) components, ECM degraders, growth factors and
collagen cross-linking-related enzymes. Sections of murine knee joints injected with Ad-TGF-b or
Ad-CTGF or from experimental OAwere stained for lysyl hydroxylase 2 (LH2). The number of pyridinoline
cross-links per triple helix collagen in synovium biopsies was determined with high-performance liquid
chromatography (HPLC).
Results: Expression of collagen alpha-1(I) chain precursor (Col1a1), tissue inhibitor of metalloproteinases
1 (TIMP1) and especially procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2b (Plod2b) were highly
upregulated by TGF-b but not by CTGF. Elevated expression of Plod2b mRNA was associated with high
lysyl hydroxylase 2 (LH2) protein staining after TGF-b overexpression and in experimental OA.
Furthermore, in experimental OA the number of hydroxypyridinoline cross-links was signiﬁcant
increased compared to control knee joints.
Conclusions: Our data show that elevated LH2b expression is associated with the persistent nature of
TGF-b-induced ﬁbrosis. Also in experimental OA, LH2b expression as well as the number of hydrox-
ypyridinoline cross-link were signiﬁcantly upregulated. We propose that LH2b, and the subsequent
increase in pyridinoline cross-links, is responsible for the persistent ﬁbrosis in experimental OA.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Important hallmarks of osteoarthritis (OA) are cartilage degen-
eration, osteophyte formation and ﬁbrosis, resulting in both joint
pain and stiffness. Fibrosis is characterized by excess connectiveP.M. van der Kraan, Radboud
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s Research Society International. Ptissue accumulation, which can occur in many organs and can lead
to organ failure1,2. In OA, ﬁbrosis is a major contributor to joint
stiffening and is involved in joint pain3. Twomain players in ﬁbrotic
diseases which are also elevated in OA are transforming growth
factor beta (TGF-b) and connective tissue growth factor (CTGF)4,5.
TGF-b controls cell proliferation, differentiation and fulﬁlls
different roles in immunity and wound healing but also plays a role
in ﬁbrosis in different organs6e12. We have previously shown that
TGF-b plays an important role in synovial ﬁbrosis in experimental
OA, as blocking TGF-b could prevent synovial ﬁbrosis13. However,
blocking TGF-b in OA is not an option as it is crucial for cartilage
maintenance and repair14,15. Besides TGF-b, CTGF has been
proposed as amajor player in ﬁbrotic diseases. CTGF can be induced
by TGF-b through a TGF-b response element, however it can also
function independent of TGF-b16e18. During adulthood, CTGF isublished by Elsevier Ltd. All rights reserved.
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promotes angiogenesis and tissue integrity19e22. When it is
expressed in other tissues it is mostly associated with wound
healing, vascular diseases and ﬁbrosis22.
By injecting an adenovirus overexpressing CTGF in murine knee
joint we previously showed that CTGF can induce synovial
ﬁbrosis23. However, in contrast to TGF-b-induced synovial ﬁbrosis,
which is persistent, CTGF overexpression resulted in ﬁbrosis that
was resorbed by day 28. Others have also found that adenoviral
expression of TGF-b induced pronouncedly prolonged ﬁbrosis,
while adenoviral expression of CTGF induced only transient
ﬁbrosis10,24. This raised the question: What causes this difference
between TGF-b and CTGF-induced ﬁbrosis, and speciﬁcally which
factor(s) are responsible for the persistent nature of TGF-b-induced
ﬁbrosis?
Fibrosis results from an imbalance between matrix synthesis
and matrix degradation. Therefore, we assessed the effect of either
TGF-b or CTGF overexpression on mRNA expression levels of
various matrix turnover related genes and whether these give an
indication of the observed differences. Thereafter we examined
whether these factor(s) play a role in OA-related ﬁbrosis.
Here we report that lysyl hydroxylase 2b is strongly induced in
TGF-b-induced persistent ﬁbrosis and not in CTGF-induced tran-
sient ﬁbrosis. Lysyl hydroxylases are collagen modifying and cross-
linking enzymes that convert lysine into hydroxylysine, thereby
leading to cross-links that make collagen harder to degrade25e29.
Especially LH2b, which hydroxylases the telopeptides and so
induces the formation of pyridinoline collagen cross-links, makes
collagen harder to degrade. LH2b and the pyridinoline cross-links it
induces were both signiﬁcantly elevated in OA-related ﬁbrosis.
Materials and methods
Animals
Male C57Bl/6 mice aged 12weeks were used. Animals were kept
in ﬁltertop cages with woodchip bedding. They were fed a standard
diet with tap water ad libitum. The local committee on animal
research and ethics has approved this study.
CTGF and TGF-b overexpression
We injected murine knee joints intra-articularly (i.a.) with
110e7 pfu virus in the right knee joint, thereby transfecting the
synovial lining with an adenovirus overexpressing active porcineTable I
Primers used for Q-PCR. Primers were accepted if the deviation from slope of the standar
melting curve showed only one product. Efﬁciencies (E) for all primer sets were determ
Gene R2 E Forward p
Gapdh 0.997 2.05 GGCAAAT
Col1a1 0.997 2.10 TGACTGGA
Mmp3 0.997 2.21 TGGAGCTG
Mmp9 0.998 2.15 GGAACTCA
Mmp13 0.992 1.93 ACCTTGTG
Adamts4 0.996 2.10 CACTGACT
Adamts5 0.994 1.97 GATGATCA
Timp1 0.972 1.93 CAACTCGG
Tgf-b1 0.996 2.00 GCAGTGG
Ctgf 0.998 2.15 CCGCCAAC
Plod1 0.997 1.90 GGAGCCG
Plod2 0.997 2.08 GAGCAGC
Plod2b 0.999 1.93 CCGCAATG
Plod3 0.993 2.02 AAGACAC
Human CTGF 0.999 2.03 GCCCTCGC
Porcine Tgf-b1 0.997 1.99 TGACCTGGTGF-b1 (Ad-TGF-b223/225) (gift from Dr. C.D. Richards) or human
CTGF (Ad-CTGF) (FibroGen, Inc., South San Francisco, CA, USA). As
a viral control Ad-luc was used. Themice were sacriﬁced on day 3, 7
and 21. Synovial biopsies from at least ﬁve individual mice per
group, were taken from the right knee joint for RNA isolation and
subsequently Q-PCR. The right knee joints of mice injectedwith Ad-
luc were used as controls for TGF-b1 and CTGF injected joints. This
experiment was repeated and whole knee joints were isolated for
histology (n¼ 6 per group). Since the adenoviruses overexpress
either porcine TGF-b or human CTGF we could distinguish these
from endogenousmurine TGF-b and CTGFwith speciﬁc primer sets.
Collagenase-induced OA
To induceOA,ﬁveunits ofbacterial collagenase ina total volumeof
6 ml were injected i.a. into the right knee joint as previously
described30. Mice were sacriﬁced on day 7, 21, and 42 and synovial
biopsies were taken for RNA isolation (n¼ 4 per group*). This exper-
iment was repeated for pyridinoline cross-link measurement and
synovial biopsieswere takenatday2,7, 21, and42 (n¼ 12pergroup*).
Wholeknee jointswere isolated forhistology (n¼ 10per group*) (day
7, 28 and 42). The left non-injected knee joints served as controls. The
injection of bacterial collagenase leads to joint laxity and subsequent
OA lesions resembling those occurring naturally in old mice. This
model represents an equivalent to human secondary OA resulting
from joint instability. *Each number represents an individual mouse.
Quantitative PCR (Q-PCR)
RNA was isolated from the synovial biopsies with an RNeasy
Mini Kit (Qiagen Inc., Valencia, CA, USA) after which an reverse
transcriptase PCR (RT-PCR) was performed. Q-PCR was performed
on the StepOnePlus Real-Time PCR System (Applied Biosystems,
Darmstadt, Germany) according to manufacturers protocol. The
used primer sets are displayed in Table I. Ct values of the genes of
interest were corrected for glyceraldehyde-3-phosphate dehydro-
genase (Gapdh) and there corresponding controls (delta delta Ct
(DDCt)). Each biological sample was measured once.
Histology and immunohistochemistry
The murine knee joints were processed and immunohis-
tochemically stained as previously described14. Speciﬁc primary
Abs against LH2 (1/100) (Proteintech Group Inc., Chicago, IL, USA)
were incubated overnight at 4C. The second antibody biotinylatedd curve was less than 0.3 compared to the slope of GAPDH standard curve and if the
ined using a standard curve of ﬁve serial cDNA dilutions in water in duplicate
rimer (50/ 30) Reverse primer (50/ 30)
TCAACGGCACA GTTAGTGGGGTCTCGCTCCTG
AGAGCGGAGAGTACT CCTTGATGGCGTCCAGGTT
ATGCATAAGCCC TGAAGCCACCAACATCAGGA
CACGACATCTTCCA GAAACTCACACGCCAGAAGAATTT
TTTGCAGAGCACTAACTT CTTCAGGATTCCCGCAAGAGT
TCCTGGACAATGGTTAT GGAAAAGTCGTCGGTAGATGGA
CGAAGAGCACTACGA TCACATGAATGATGCCCACAT
ACCTGGTCATAAGG CATCTTGATCTTATAACGCTGGTATAAGG
CTGAACCAAGGA AAGAGCAGTGAGCGCTGAATC
CGCAAGATC ACCGACCCACCGAAGACA
AACAGCCTAAGG TGAGTGGCGCAATGACATTC
CTTGTCCAGATGTC CCAACTCATCACAGGCTCGTT
CTAGAGATATGACCTT CATTTGGAATGTTTCCGGAGTAG
GGGCAGTGATGAACT AAGCGAGGGCTGCTCATCT
GGCTTACC AGGCAGTTGGCTCTAATCATAGTTG
CCACCATTCAT TCCGTGGAGCTGAAGCAATA
Table II
Ct values of human CTGF and porcine TGF-b. Mice were injected i.a. with an
adenovirus encoding either TGF-b or CTGF or a control virus. Three, 7 and 21 days
after injection of the adenovirus synovial biopsy punches were taken of which RNA
was isolated. Primers detecting only viral CTGF (human, not murine) and only viral
TGF-b (porcine, notmurine)were used to evaluatewhether expressionwas sustained
over a period of time. Ct values were corrected for Gapdh. Higher Ct values thus
represent a lower expression. Nd¼ not detectable. Clearly, viral CTGF was only found
in synovial biopsy punches of mice injected with Ad-CTGF and viral TGF-b was only
detected in synovial biopsy punches of mice injected with Ad-TGF-b. The expression
levels declined in time, but expression was still clearly detectable at day 21
Sample Human CTGF Porcine TGF-b
Control virus day 3 Nd Nd
Control virus day 7 Nd Nd
Control virus day 21 Nd Nd
Ad-TGF-b day 3 Nd 9.6
Ad-TGF-b day 7 Nd 11.2
Ad-TGF-b day 21 Nd 13.6
Ad-CTGF day 3 7 Nd
Ad-CTGF day 7 10.2 Nd
Ad-CTGF day 21 13.0 Nd
Fig. 1. mRNA expression (DDCt) of endogenous TGF-b and CTGF in murine synovial
tissue. Mice were injected i.a. with an adenovirus encoding either TGF-b1 or CTGF.
Three, 7 and 21 days after injection of the adenovirus, synovial biopsy punches
were taken of which RNA was isolated. DDCt values were calculated by correcting the
Ct values of the genes of interest for GAPDH and there corresponding controls. (A)
TGF-b induced elevated levels of TGF-b1 RNA. In addition, Ad-TGF-b overexpression
resulted in elevation of CTGF RNA expression. (B) Ad-CTGF only resulted in a signiﬁcant
(P¼ 0.02) increase of TGF-b on day 7. The endogenous levels of CTGF were not affected
by Ad-CTGF.
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biotinestreptavidin detection system was used according to the
manufacturer’s protocol (Vector Laboratories). Sections were
counterstained with hematoxylin and mounted with Permount.
The presence of ﬁbrosis was determined by the synovial thick-
ening, due to the accumulation of extracellular matrix and increase
in ﬁbroblasts (histology), and at the increase in collagen alpha-1(I)
chain precursor (Col1a1) gene expression (Q-PCR).
Cross-link measurement
Synovial tissue samples (n¼ 12) were hydrolyzed in an oven
with 6 M HCl at 110C for 20 h. After drying (Speed Vac) samples
were dissolved in 100 ml internal standard. The amount of
hydroxyproline (Hyp) and the cross-links lysylpyridinoline (LP) and
hydroxylysylpyridinoline (HP) in these samples were determined
by reversed-phase high-performance liquid chromatography
(HPLC) as described by Bank et al.31. To calculate the amount of HP
per triple helix the amount of HP (pmol) in the sample was divided
by the total amount of collagen (¼Hyp/300). Values are expressed
as total amount of residues per collagen molecule, assuming 300
Hyp residues per triple helix.
Statistical analysis
First all data were checked for normality with the ShapiroeWilk
test. To determine signiﬁcant (P< 0.05) differences between groups
that were normally distributed a One-Way ANOVA with Gamese
Howell post hoc test for multiple comparison was performed.
Signiﬁcant (P< 0.05) differences between groups that were not
normally distributed were determined with the Wilcoxon Signed
Ranks Test. The statistical analyses were performed with the
statistical software package SPSS 18.0 (SPSS, Chicago, IL, USA).
Results
To address the question which factors could be responsible for
difference in TGF-b-induced persistent and CTGF-induced transient
ﬁbrosis, we evaluated the expression of several extracellular matrix
components, matrix proteases, as well as growth factor expression
andmodulators of collagen cross-linking. First we checkedwhether
the adenoviruses, which were intra-articular injected in the right
murine knee joint, induced expression of human CTGF and porcine
TGF-b. This showed clear expression of both factors until at least
day 21 (Table II).
Ad-TGF-b induces both endogenous TGF-b and CTGF mRNA
expression
We examined the effect of adenoviral overexpression of CTGF or
TGF-b on the endogenous expression of CTGF and TGF-b. Adeno-
viral overexpression of TGF-b induced relatively high levels of
endogenous (murine) TGF-b1 and CTGF, with maximal induction
levels of 3.5 DDCt (P< 0.0001) for TGF-b1 at day 7 and 3.8 DDCt
(P< 0.0001) for CTGF on day 3 [Fig. 1(A)]. Adenoviral over-
expression of CTGF only resulted in a small increase (1.3 DDCt) of
TGF-b on day 7. Further there were hardly any changes induced by
Ad-CTGF with regard to the endogenous expression levels of CTGF
and TGF-b [Fig. 1(B)].
Elevated gene expression of Mmp3/9/13, Adamts4 and Timp1 by
Ad-TGF-b
TGF-b induced the expression of most of the studied matrix
metalloproteinases (MMPs), a disintegrin and metalloproteinasewith thrombospondin motifs (ADAMTSs) and tissue inhibitor of
metalloproteinases 1 (Timps). Expression of Mmp13 and Adamts4
were strongly elevated on all measured days [Fig. 2(A)]. Timp1
expression was highly elevated by TGF-b overexpression with
a maximum at day 7 of 5.8 DDCt (P< 0.0004) compared to normal
expression. Compared to TGF-b, CTGF only signiﬁcantly induced
Fig. 2. mRNA expression (DDCt) of various enzymes in the synovial tissue. Mice were injected i.a. with an adenovirus encoding either TGF-b or CTGF. Three, 7 and 21 days after
injection of the adenovirus synovial biopsy punches were taken of which RNA was isolated. DDCt values were calculated by correcting the Ct values of the genes of interest for
GAPDH and for control samples. (A) Ad-TGF-b induced the highest changes on day 7, with most marked changes in expression of MMP3, MMP13, ADAMTS4 and TIMP1. (B)
Overexpression of Ad-CTGF resulted in a signiﬁcant induction of MMP3 (P¼ 0.008) and ADAMTS4 (P¼ 0.017) at day 7. MMP9 was downregulated by Ad-CTGF at day 7 (P¼ 0.003)
and 21 (P¼ 0.011).
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any of the measured expression levels more than 1.5DDCt [Fig. 2(B)].
Ad-TGF-b, but not Ad-CTGF, induces procollagen-lysine,
2-oxoglutarate 5-dioxygenase 2b (Plod2b) mRNA expression in
murine synovium
Since, collagen cross-linking can have a major impact on the
degradation of collagen we also evaluated the levels of mRNA
expression of the lysyl hydroxylases (enzymes involved in collagen
cross-linking). The family of lysyl hydroxylases consists of: LH1, LH2
and LH3 which are coded by Plod1, Plod2, and Plod3 respectively.
LH2 has two alternative splice-variants: LH2a and LH2b. TGF-
b induced all Plods with the highest expression on day 7 [Fig. 3(A)].
Strikingly, TGF-b overexpression resulted in very high Plod2b
expression levels, with an induction of approximately 4 DDCT
(P< 0.003) on all measured days. Adenoviral overexpression of
TGF-b also resulted in elevated expression levels of Col1a1mRNA in
synovium on all measured days, with a maximum increase (4.7
DDCt; P< 0.0001) on day 7 compared to controls [Fig. 3(A)]. CTGF
had no effect on Plod gene expression levels on day 3 and day 7, at
day 21 Plod2(b) and Plod3 were somewhat downregulated but this
was not signiﬁcant [Fig. 3(B)]. In contrast to TGF-b, and rather
unexpected, CTGF did not induce the expression of Col1a1.
Ad-TGF-b-induces persistent ﬁbrosis which is accompanied by
elevated LH2 protein expression
Having found a particularly high Plod2(b) gene expression in the
synovium, we investigated if this translates into LH2 protein
expression. To this end, we stained parafﬁn sections of the murineknee joint transduced with either CTGF or TGF-b for LH2. First we
investigated if the synovium was thickened. After TGF-b over-
expression there was a strong increase in the thickness of the
synovium over time, which was still present on day 21 [Fig. 4(C)].
CTGF overexpression resulted in synovial ﬁbrosis with a peak on
day 7, which was completely resolved on day 28 [Fig. 4(B)]. These
results support our earlier published observations that over-
expressing TGF-b leads to persistent ﬁbrosis whereas CTGF induces
transient ﬁbrosis. Similar to LH2b mRNA expression after TGF-b
overexpression, LH2 protein expression was the highest on day 21
[Fig. 4(C)]. However, on day 3 and 7 there was also a clear increase
in LH2 protein expression compared to the control knee joints. As
expected, CTGF did not inﬂuence LH2 protein expression [Fig. 4(B)].
Plod2b mRNA is elevated in collagenase-induced OA
Because Plod2b was strongly upregulated in TGF-b-induced
persistent ﬁbrosis we investigated if Plod2b was also elevated in
OA-related synovial ﬁbrosis in collagenase-induced OA. We found
that in collagenase-induced OA there was a signiﬁcant and long-
lasting increase of Plod2b gene expression. The highest induction
of 6.3 DDCt (P< 0.0001) was measured on day 7, however Plod2b
was still signiﬁcant increased on day 21 and 42 [Fig. 5(A)]. Thus,
comparable to TGF-b-induced ﬁbrosis, Plod2b gene expression is
also elevated in experimental OA-related ﬁbrosis.
LH2 protein expression is strongly induced in OA-related ﬁbrosis
Histological sections of murine knee joints were stained for LH2,
to assess if LH2 protein expression was induced in OA-related
ﬁbrosis. A clear increase in LH2 protein expression was observed in
Fig. 3. mRNA expression (DDCt) of various lysyl hydroxylases and Col1a1 in the synovial tissue. Mice were injected i.a. with an adenovirus encoding either TGF-b or CTGF. At day 3, 7
and 21 after injection of the adenovirus synovial biopsy punches were taken for RNA isolation. DDCt values were calculated by correcting the Ct values of the genes of interest for
GAPDH and for control samples. (A, B) In contrast to CTGF, TGF-b induced expression levels of all measured Plods. The most marked change was observed in Plod2(b) expression,
which was strongly induced on all measured days. Col1a1 expression was also induced after Ad-TGF-b overexpression but not after Ad-CTGF overexpression.
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day 7 there was a very strong increase in LH2 expression, while on
both day 21 and 42 LH2 protein expression was still elevated but
less intense than on day 7. The thickness of the synovium of the
murine knee joints with collagenase-induced OA was mildly
increased at day 7, while a large increase was seen on day 28 and
42. LH2 protein expression being strongly elevated in collagenase-
induced OA, indicating LH2(b) may play a key role in OA-related
ﬁbrosis.
Elevated number of HP cross-links in synovium in experimental OA
To determine whether a higher LH2b expression level results in
an increase of pyridinoline cross-links, the number of LP and HP per
triple helix was measured in the synovium of mice with
collagenase-induced OA. The amount of LP was under the detection
limit at all measured time points. However, there was a signiﬁcant
increase in the number of HP cross-links per triple helix on both
day 21 and 42, with a 1.8-fold increase on day 21 and a 2.6-fold
increase on day 42 compared to unaffected left control joints
[Fig. 5(C)]. This indicates that elevated levels of LH2b expression
during experimental OA indeed result in more pyridinoline cross-
links per triple helix. Suggesting the formation of more
degradation-resistant collagen27.
Discussion
Synovial ﬁbrosis is thought to contribute signiﬁcantly to joint
stiffness3. Previously we have shown that TGF-b induces persistent
ﬁbrosis whereas CTGF induces reversible ﬁbrosis23,32,33. In this
study we evaluated several factors to get an indication why TGF-
b induces persistent ﬁbrosis and CTGF induces only transient
synovial ﬁbrosis and whether the factors are involved in thepersistent nature of OA-related ﬁbrosis. The most pronounced and
abundant induction we detected was the induction of LH2b by
TGF-b. In addition, we found that LH2b gene expression and LH2
protein expression as well as the number of pyridinoline cross-links
per triple helix were strongly induced in experimental OA.
First we explored if the endogenous levels of TGF-b1, and CTGF
were altered by overexpressing either TGF-b or CTGF. Over-
expression of TGF-b resulted in the induction of endogenous TGF-b
and CTGF, whereas overexpressing CTGF had no noteworthy effects
on endogenous CTGF and TGF-b. TGF-b autoinduction could
contribute to the potentiation of TGF-b induced effects. However,
TGF-b-induced ﬁbrosis persists for months whereas TGF-b auto-
induction strongly diminished in time. Therefore it is unlikely that
TGF-b autoinduction is the cause of the persistence of TGF-b-
induced ﬁbrosis.
As expected, endogenous CTGF was induced by overexpressing
TGF-b. In contrast to our ﬁnding, several other groups have estab-
lished that ﬁbrosis induced by TGF-b alone was not persistent and
that only simultaneous application of CTGF and TGF-b resulted in
long-term ﬁbrotic tissue formation in skin of mice34e36. In our
system, TGF-b was sufﬁcient to maintain ﬁbrosis maybe supported
by the induced CTGF. Our results show that Ad-CTGF over-
expression, which induces high CTGF expression, gives mild and
transient ﬁbrosis. Since CTGF alone only induces transient ﬁbrosis,
CTGF is most likely not the factor responsible for the persistence of
TGF-b induced ﬁbrosis.
Expression of Col1a1 mRNA levels was highly upregulated by
TGF-b when compared to CTGF or controls. We expected Col1a1
upregulation by both TGF-b and CTGF, but we found almost no
upregulation after Ad-CTGF exposure. This was unexpected as type
1 collagen is the major component of ﬁbrosis and has frequently
been found upregulated by CTGF17,24,37,38. However, Bonniaud et al.
found a 3-fold upregulation of Col1a1 mRNA at day 14 after Ad-
Fig. 4. (A) Normal murine knee joint, with the area that is displayed in the histology ﬁgures. (B, C) Immunohistochemically staining for LH2 protein expression in the synovial tissue
of murine knee joints after i.a. of CTGF or TGF-b. TGF-b overexpression resulted in a strong increase over time in the thickness of the synovial membrane starting at day 3. CTGF-
induced ﬁbrosis was most abundant at day 7 and was completely resorbed at day 28. In contrast to CTGF, overexpressing of TGF-b strongly induced LH2 expression in the synovium,
especially at day 21 (Original magniﬁcation 100).
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mately 1.5-fold) in Col1a1 mRNA expression on day 3 and 7 and
approximately 0.75 at day 2124. Thus, we might have missed the
window in which this increased expression could have been
present.Fig. 5. (A) Plod2b mRNA expression (DDCt) in the synovial tissue of murine knee joints w
measured days in the synovium of OA-affected joint compared to the healthy control joints.
DDCt increased at day 21. (B) Immunohistochemically staining for LH2 protein on murine k
focused at the synovial tissue lateral of the growth plate (see [Fig. 3(A)]). At day 7 a mild in
a strong increase in synovial thickening was observed. LH2 expression was strongly induce
compared to day 7. (C) HPLC cross-link measurement in synovial punches, obtained from m
links per triple helix was signiﬁcantly elevated on day 21 and 42 in the synovium of murinHigh type 1 collagen production maybe crucial in the building
up process of ﬁbrosis. However type 1 collagen, without an eleva-
tion in the number of pyridinoline cross-links can be degraded by
different enzymes and may therefore have a limited role in the
persistence of ﬁbrosis. We expected that the reversibility observedith collagenase-induced OA. Plod2b mRNA expression was signiﬁcantly induced on all
This increase was with an induction of 6.3 DDCt the strongest on day 7, but was still 1.6
nee joints with collagenase-induced OA (Original magniﬁcation 100). The picture is
crease in the thickness of the synovial membrane was seen whereas on day 28 and 42
d in the synovium at day 7, on day 28 and 42 LH2 was still elevated but less intense
ice with collagenase-induced OA (n¼ 12 per group). The number of pyridinoline cross-
e knee joints with collagenase-induced OA compared to unaffected left control joints.
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degradation, but in fact TGF-b led to elevated levels of MMP
expression, whereas CTGF hardly inﬂuenced the expression of the
proteases explored. TGF-b also induced elevated Timp1 expression,
proteins that are able to inhibit MMPs and might prevent or reduce
MMP-mediated matrix degradation. The outcome of the effect of
Timp1 on TGF-b-induced synovial ﬁbrosis is probably determined
by the balance between the TIMPs and MMPs. The increase at day
21 in Mmp13 mRNA expression was higher than Timp1 mRNA
expression, suggestive for Timp1 not being responsible for the
persistence of TGF-b-induced ﬁbrosis. The net effect of this balance
on matrix turnover however is hard to predict.
Since the previous described genes did not clarify the persistent
nature of TGF-b induced ﬁbrosis, we also examined differences in
collagen cross-linking enzymes. A prominent observation was that
TGF-b induced high expression of Plod2 in the synovium, especially
Plod2b, whereas CTGF did not induce any signiﬁcant changes in Plod
mRNA expression levels. That TGF-b is able to induce Plod2/LH2b
was earlier shown by van der Slot et al. in skin ﬁbroblasts25. They
also showed that ﬁbroblasts of several ﬁbrotic disorders had
increased levels of Plod2/LH2b mRNA expression. Induced LH2b
results in overhydroxylation of lysine residues within collagen
telopeptides which leads to increased formation of pyridinoline
cross-links, making collagen harder to degrade by proteases27,39,40.
This could explain why the elevated Mmp13 and Adamts4 mRNA
levels do not interfere with the persistence of TGF-b-induced
ﬁbrosis. This also might explain why CTGF-induced ﬁbrosis is tran-
sient, whereas TGF-b-induced ﬁbrosis lingers at least for months.
We investigated if Plod2 is also involved in OA-related synovial
ﬁbrosis in collagenase-induced OA. In this OA model that is
accompanied by ﬁbrosis both Plod2b mRNA and LH2 protein
expression levels were strongly elevated. We postulated that the
strong induction of LH2b in the beginning of collagenase-induced
OA lead to overhydroxylation of lysyl groups in the telopeptides
of procollagen molecules. During the maturation process these
overhydroxylated procollagen molecules will form more pyr-
idinoline cross-links per triple helix compared to not over-
hydroxylated procollagen. We measured the amount of
pyridinoline cross-links per triple helix and as hypothesized these
were signiﬁcantly elevated on day 28 and 42. This ﬁnding was not
unexpected because collagen cross-link maturation may take
several weeks41. This increase in pyridinoline cross-links will result
in collagen that is harder to degrade, and lead to persistent ﬁbrosis
after TGF-b exposure and in experimental OA.
We have shown that LH2b gene expression and LH2 protein
were induced in both TGF-b-induced ﬁbrosis and collagenase-
induced OA-related ﬁbrosis. For different ﬁbrotic diseases an
increase in pyridinoline cross-links is reported, for instance in
systemic sclerosis, alcoholic cirrhosis, and glomerulosclerosis26.
Since these pyridinoline cross-links are increased due to the
elevated LH2b expression levels, we propose that LH2b is respon-
sible for the persistence of ﬁbrosis in OA. Most likely TGF-b, that is
elevated in OA, is the driving force of enhanced LH2b expression in
the OA process. We and other groups have shown that blocking
TGF-b prevents ﬁbrosis13,42. However, complete blockage of TGF-
b in OA is not an option as it is crucial for cartilagemaintenance and
repair. Selective blocking of LH2b in an early stage of OA may
prevent the formation of pyridinoline cross-links, and therefore
persistent ﬁbrosis. This makes LH2b an interesting target for the
treatment of OA-related synovial ﬁbrosis.
Contributions
Each author mentioned on the title page contributed sufﬁcient
to the study design, analysis of the data or acquisition of data andrevising the article. All contributing authors approved the article to
be published.
Role of the funding source
Funding only.
Conﬂict of interest
The authors have no conﬂict of interest.
Acknowledgment
The authors would like to thank N. Oliver (FibroGen, Inc., 225
Gateway Boulevard, South San Francisco, CA 94080, USA) for the
Ad-CTGF virus.
This study was supported by a grant from the Dutch Arthritis
Association (grant NR 09-1-403).
References
1. Gonzalez A, Lopez B, Diez J. Fibrosis in hypertensive heart
disease: role of the renineangiotensinealdosterone system.
Med Clin North Am 2004;88:83e97.
2. Krieg T, Abraham D, Lafyatis R. Fibrosis in connective tissue
disease: the role of the myoﬁbroblast and ﬁbroblast-epithelial
cell interactions. Arthritis Res Ther 2007;9(Suppl 2):S4.
3. Hill CL, Hunter DJ, Niu J, Clancy M, Guermazi A, Genant H, et al.
Synovitis detected on magnetic resonance imaging and its
relation to pain and cartilage loss in knee osteoarthritis. Ann
Rheum Dis 2007;66:1599e603.
4. Leask A, Abraham DJ. TGF-beta signaling and the ﬁbrotic
response. FASEB J 2004;18:816e27.
5. Schlaak JF, Pfers I, Meyer Zum Buschenfelde KH, Marker-
Hermann E. Different cytokine proﬁles in the synovial ﬂuid of
patients with osteoarthritis, rheumatoid arthritis and sero-
negative spondylarthropathies. Clin Exp Rheumatol 1996;14:
155e62.
6. Border WA, Noble NA. TGF-beta in kidney ﬁbrosis: a target for
gene therapy. Kidney Int 1997;51:1388e96.
7. Lim H, Zhu YZ. Role of transforming growth factor-beta in
the progression of heart failure. Cell Mol Life Sci 2006;63:
2584e96.
8. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. Inhibition
of transforming growth factor beta prevents progression of
liver ﬁbrosis and enhances hepatocyte regeneration in
dimethylnitrosamine-treated rats. Hepatology 2000;32:
247e55.
9. Schultze-Mosgau S, Wehrhan F, Rodel F, Amann K, Radespiel-
Troger M, Kopp J, et al. Anti-TGFbeta1 antibody for modulation
of expression of endogenous transforming growth factor beta
1 to prevent ﬁbrosis after plastic surgery in rats. Br J Oral
Maxillofac Surg 2004;42:112e9.
10. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovector-
mediated gene transfer of active transforming growth factor-
beta1 induces prolonged severe ﬁbrosis in rat lung. J Clin
Invest 1997;100:768e76.
11. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against
transforming growth factor-beta 1 suppress intimal hyper-
plasia in a rat model. J Clin Invest 1994;93:1172e8.
12. Gordon KJ, Blobe GC. Role of transforming growth factor-beta
superfamily signaling pathways in human disease. Biochim
Biophys Acta 2008;1782:197e228.
13. Scharstuhl A, Vitters EL, van der Kraan PM, van den Berg WB.
Reduction of osteophyte formation and synovial thickening by
adenoviral overexpression of transforming growth factor beta/
D.F.G. Remst et al. / Osteoarthritis and Cartilage 21 (2013) 157e164164bone morphogenetic protein inhibitors during experimental
osteoarthritis. Arthritis Rheum 2003;48:3442e51.
14. Blaney Davidson EN, Scharstuhl A, Vitters EL, van der
Kraan PM, van den Berg WB. Reduced transforming growth
factor-beta signaling in cartilage of old mice: role in impaired
repair capacity. Arthritis Res Ther 2005;7:R1338e47.
15. Blaney Davidson EN, Vitters EL, van der Kraan PM, van den
Berg WB. Expression of transforming growth factor-beta
(TGFbeta) and the TGFbeta signalling molecule SMAD-2P in
spontaneous and instability-induced osteoarthritis: role in
cartilage degradation, chondrogenesis and osteophyte forma-
tion. Ann Rheum Dis 2006;65:1414e21.
16. Blom IE, Goldschmeding R, Leask A. Gene regulation of
connective tissue growth factor: new targets for antiﬁbrotic
therapy? Matrix Biol 2002;21:473e82.
17. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H,
Huang X, et al. Connective tissue growth factor mediates
transforming growth factor beta-induced collagen synthesis:
down-regulation by cAMP. FASEB J 1999;13:1774e86.
18. Kothapalli D, Hayashi N, Grotendorst GR. Inhibition of TGF-
beta-stimulated CTGF gene expression and anchorage-
independent growth by cAMP identiﬁes a CTGF-dependent
restriction point in the cell cycle. FASEB J 1998;12:1151e61.
19. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. Connec-
tive tissue growth factor: a cysteine-rich mitogen secreted by
human vascular endothelial cells is related to the SRC-induced
immediate early gene product CEF-10. J Cell Biol 1991;114:
1285e94.
20. Heuer H, Christ S, Friedrichsen S, Brauer D, Winckler M,
Bauer K, et al. Connective tissue growth factor: a novel marker
of layer VII neurons in the rat cerebral cortex. Neuroscience
2003;119:43e52.
21. Surveyor GA, Wilson AK, Brigstock DR. Localization of
connective tissue growth factor during the period of embryo
implantation in the mouse. Biol Reprod 1998;59:1207e13.
22. Friedrichsen S, Heuer H, Christ S, Cuthill D, Bauer K, Raivich G.
Gene expression of connective tissue growth factor in adult
mouse. Growth Factors 2005;23:43e53.
23. Blaney Davidson EN, Vitters EL, Mooren FM, Oliver N,
Berg WB, van der Kraan PM. Connective tissue growth
factor/CCN2 overexpression in mouse synovial lining results
in transient ﬁbrosis and cartilage damage. Arthritis Rheum
2006;54:1653e61.
24. Bonniaud P, Margetts PJ, Kolb M, Haberberger T, Kelly M,
Robertson J, et al. Adenoviral gene transfer of connective tissue
growth factor in the lung induces transient ﬁbrosis. Am J
Respir Crit Care Med 2003;168:770e8.
25. van der Slot AJ, van Dura EA, de Wit EC, De Groot J,
Huizinga TW, Bank RA, et al. Elevated formation of pyridino-
line cross-links by proﬁbrotic cytokines is associated with
enhanced lysyl hydroxylase 2b levels. Biochim Biophys Acta
2005;1741:95e102.
26. van der Slot AJ, Zuurmond AM, van den Bogaerdt AJ,
Ulrich MM, Middelkoop E, Boers W, et al. Increased formation
of pyridinoline cross-links due to higher telopeptide lysyl
hydroxylase levels is a general ﬁbrotic phenomenon. Matrix
Biol 2004;23:251e7.
27. van der Slot-Verhoeven AJ, van Dura EA, Attema J, Blauw B,
Degroot J, Huizinga TW, et al. The type of collagen cross-linkdetermines the reversibility of experimental skin ﬁbrosis.
Biochim Biophys Acta 2005;1740:60e7.
28. Ryhanen L, Kivirikko KI. Hydroxylation of lysyl residues in
native and denatured protocollagen by protocollagen lysyl
hydroxylase in vitro. Biochim Biophys Acta 1974;343:129e37.
29. van der Slot AJ, Zuurmond AM, Bardoel AF, Wijmenga C,
Pruijs HE, Sillence DO, et al. Identiﬁcation of PLOD2 as telo-
peptide lysyl hydroxylase, an important enzyme in ﬁbrosis.
J Biol Chem 2003;278:40967e72.
30. van der Kraan PM, Vitters EL, van Beuningen HM, van de
Putte LB, van den Berg WB. Degenerative knee joint lesions in
mice after a single intra-articular collagenase injection. A new
model of osteoarthritis. J Exp Pathol (Oxford) 1990;71:19e31.
31. Bank RA, Beekman B, Verzijl N, de Roos JA, Sakkee AN,
TeKoppele JM. Sensitive ﬂuorimetric quantitation of pyr-
idinium and pentosidine crosslinks in biological samples in
a single high-performance liquid chromatographic run.
J Chromatogr B Biomed Sci Appl 1997;703:37e44.
32. Bakker AC, van de Loo FA, van Beuningen HM, Sime P, van
Lent PL, van der Kraan PM, et al. Overexpression of active TGF-
beta-1 in the murine knee joint: evidence for synovial-layer-
dependent chondro-osteophyte formation. Osteoarthritis
Cartilage 2001;9:128e36.
33. van Beuningen HM, van der Kraan PM, Arntz OJ, van den
Berg WB. Does TGF-beta protect articular cartilage in vivo?
Agents Actions Suppl 1993;39:127e31.
34. Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M,
et al. Connective tissue growth factor causes persistent
proalpha2(I) collagen gene expression induced by trans-
forming growth factor-beta in a mouse ﬁbrosis model. J Cell
Physiol 2005;203:447e56.
35. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T,
Igarashi A, et al. Role and interaction of connective tissue
growth factor with transforming growth factor-beta in
persistent ﬁbrosis: a mouse ﬁbrosis model. J Cell Physiol
1999;181:153e9.
36. Takehara K. Hypothesis: pathogenesis of systemic sclerosis.
J Rheumatol 2003;30:755e9.
37. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR.
Stimulation of ﬁbroblast cell growth, matrix production, and
granulation tissue formation by connective tissue growth
factor. J Invest Dermatol 1996;107:404e11.
38. Gore-Hyer E, Shegogue D, Markiewicz M, Lo S, Hazen-
Martin D, Greene EL, et al. TGF-beta and CTGF have over-
lapping and distinct ﬁbrogenic effects on human renal cells.
Am J Physiol Renal Physiol 2002;283:F707e16.
39. Bailey AJ, Light ND. Intermolecular cross-linking in ﬁbrotic
collagen. Ciba Found Symp 1985;114:80e96.
40. Ricard-Blum S, Esterre P, Grimaud JA. Collagen cross-linking by
pyridinoline occurs in non-reversible skin ﬁbrosis. Cell Mol
Biol (Noisy-le-grand) 1993;39:723e7.
41. Last JA, King Jr TE, Nerlich AG, Reiser KM. Collagen cross-
linking in adult patients with acute and chronic ﬁbrotic lung
disease. Molecular markers for ﬁbrotic collagen. Am Rev Respir
Dis 1990;141:307e13.
42. Yata Y, Gotwals P, Koteliansky V, Rockey DC. Dose-dependent
inhibition of hepatic ﬁbrosis in mice by a TGF-beta soluble
receptor: implications for antiﬁbrotic therapy. Hepatology
2002;35:1022e30.
